Company Registry

LambdaVision Inc
Profile last edited on: 8/7/2020

Retinal implant to restore vision
Year Founded
First SBIR Year
Latest SBIR Award
Program Status


Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

400 Farmington Avenue
Farmington, CT 06032
   (860) 486-6593
Multiple Locations:   
Congressional District:   05
County:   Hartford

Public Profile

With close ties to University of Connecticut, LambdaVision isorganized around the design and development of an innovative, protein-based retinal implant that utilizes the light-activated protein, bacteriorhodopsin, to stimulate the retina of patients suffering from impaired vision or loss of sight due to retinal degenerative diseases, including age-related macular degeneration (AMD) and retinitis pigmentosa (RP). Current treatments of RP and AMD only slow disease progression. LambdaVision is dedicated to creating a retinal prosthesis that is capable of restoring high-resolution vision and enhancing the quality of life for those afflicted by retinal degeneration.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Key People / Management

  Nicole L Wagner -- President and Chief Executive Officer

  Constance R Birge -- Adminstrative Specialist

  Robert Richards Birge -- Founder

  Jordan A Greco -- Director of Operations

  Maximilian Vargas -- Director Of Commercial Strategy and Market Access

SBIR firms in the news

There are no news available.